Effects of Intradialytic Aerobic Exercise in Chronic Kidney Patients
IAECKD
1 other identifier
interventional
90
0 countries
N/A
Brief Summary
The goal of this clinical trial is to evaluate the effects of intradialytic aerobic exercise on muscle capacity, functionality and motivation of patients with chronic kidney disease undergoing hemodialysis. The main question it aims to answer are: • Is intradialytic aerobic exercise at moderate intensity effective in improving peripheral muscle function, functional status and motivation in patients with chronic kidney disease?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2023
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 5, 2023
CompletedFirst Posted
Study publicly available on registry
September 26, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 14, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
September 26, 2023
September 1, 2023
2.6 years
June 5, 2023
September 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
six minute step test
A step 20 centimeters high will be used and the patient will be instructed to go up and down it as many times during the 6 minutes, according to free cadence and will be instructed not to use the upper limbs
12 weeks
Secondary Outcomes (9)
muscle strength
12 weeks
Daily life physical activity
12 weeks
Behavior Regulation Questionnaire for Physical Exercise
12 weeks
index of self-determination and basic psychological needs
12 weeks
Pittsburg Sleep Quality Index
12 weeks
- +4 more secondary outcomes
Study Arms (2)
Training group
EXPERIMENTALAerobic exercise training on moderate intensity.
Control group
NO INTERVENTIONMonitoring.
Interventions
The training group will receive aerobic exercise and the intensities will be controlled considering the percentage of estimated maximum heart rate. The training will be performed with a cycle ergometer with a total of 40 minutes of intradialytic aerobic exercise in the training group. To reduce the effects of intolerance to aerobic exercise, a week of adaptation will be performed, with a frequency of three sessions, in the first two hours of hemodialysis, lasting 40 minutes at maximum heart rate intensity of up to 74% and BORG up to 4 (low intensity). Afterwards, the patients will perform the prediction training for 12 weeks, at the frequency of three training sessions per week in the first two hours of hemodialysis. Each training session will start with a 5-minute warm-up at low intensity, 30 minutes of main training with maximum heart rate intensity 55% to 74% and BORG 5 to 7 (moderate intensity) and will end with a 5-minute cool-down at low intensity.
Eligibility Criteria
You may qualify if:
- diagnosis of chronic kidney disease undergoing renal replacement therapy via hemodialysis
- aged 20 to 65 years
- low body mass index at overweight (21 kg/m2 to 29.9 kg/m2)
- regular renal replacement therapy via hemodialysis for 6 months, without acute complications related to the diagnosis and/or comorbidities for the period of 3 months prior to the evaluation and intervention.
You may not qualify if:
- patients who do not reach a score equal to or above 20 assessed by the Mini Mental State Examination
- severe heart failure according to the New York Heart Association classification
- musculoskeletal alteration that prevents the correct execution of the assessment activities
- who have participated in other exercise protocols in the last 6 months prior to the present study
- patients who show signs of clinical instability during the hemodialysis procedure or after training for two consecutive sessions will be excluded throughout the protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doctoral student
Study Record Dates
First Submitted
June 5, 2023
First Posted
September 26, 2023
Study Start
November 1, 2023
Primary Completion (Estimated)
June 14, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
September 26, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share